Omnicell Inc
OMCL
Detailliertes Diagramm anzeigen
32.260USD
+0.430+1.35%
Handelsschluss 09/15, 16:00（ET）Kurse um 15 Minuten verzögert
1.50BMarktkapitalisierung
64.86KGV TTM
Intraday
1m
30m
1h
D
W
M
D
Heute
+1.35%
5 Tage
-0.22%
1 Monat
+1.80%
6 Monate
-2.24%
Seit Jahresbeginn
-27.54%
1 Jahr
-25.25%
Detailliertes Diagramm anzeigen
TradingKey Aktien-Score
Währung: USD Aktualisiert：2025-09-15Wichtige Einblicke
Die Fundamentaldaten des Unternehmens sind relativ sehr gesund. Seine Bewertung wird als angemessen bewertet angesehen,und die institutionelle Anerkennung ist sehr hoch. In den letzten 30 Tagen haben mehrere Analysten die Aktie mit einer Kaufen bewertet. Trotz einer schwachen Aktienmarktperformance zeigt das Unternehmen starke Fundamentaldaten und technische Indikatoren. Der Aktienkurs bewegt sich seitwärts zwischen den Unterstützungs- und Widerstandsniveaus, was ihn für schwankungsorientiertes Trading geeignet macht.
Aktienbewertung
Widerstand & Unterstützung
Keine Daten
Radar Chart
Aktueller Preis
Vorher
Analysten-Ziel
Basierend auf insgesamt
8
Analysten
Kaufen
Aktuelles Rating
44.000
Kursziel
+38.23%
Aufwärtspotenzial
Hinweis: Analystenbewertungen und Kursziele werden von LSEG ausschließlich zu Informationszwecken bereitgestellt und stellen keine Anlageberatung dar.
Unternehmens-Highlights
HöhepunkteRisiko
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
high_profit_growth
high_profit_growth_desc%!(EXTRA string=121.87)
performance_turn_profit
performance_turn_profit_desc%!(EXTRA string=12.53M, int=2)
valuation_overestimated
valuation_overestimated_desc%!(EXTRA string=PE, string=64.14)
institutional_decreasing_position
institutional_decreasing_position_desc%!(EXTRA string=49.10M, string=15.98%)
institutional_hold%!(EXTRA string=The Vanguard)
institutional_hold_desc%!(EXTRA string=The Vanguard, string=5.62M)
Nachrichten
Bald gibt es mehr Neuigkeiten, bleiben Sie dran...
Finanzindikatoren
EPS
Keine Daten
Gesamteinnahmen
Keine Daten
Unternehmen
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
BörsenkürzelOMCL
UnternehmenOmnicell Inc
CEOMr. Randall A. Lipps
Websitehttps://www.omnicell.com/
Verwandte Finanzinstrumente
-1.04%
-3.49%
-2.77%
-0.79%
-0.06%
-1.96%
+0.39%
+1.94%
+1.73%
-0.11%
+1.24%
+6.10%
-1.01%
+1.36%
-2.04%
+3.75%
-0.24%
-1.13%
+0.09%
+1.23%
